Communicators

EnWave Signs Technology Evaluation and

License Option Agreement with Perdue Farms Incorporated

Vancouver, B.C., April 13, 2015

EnWave Corporation (TSX-V:ENW | FSE:E4U) - http://bit.ly/1zBptTo - (“EnWave”, or the "Company") is pleased to announce that Perdue Farms Incorporated (“Perdue”), a leading food and agricultural products company, has signed a Technology Evaluation and License Option Agreement (the “Agreement”) for a research and development program and marketing study.

The Agreement grants Perdue the right to evaluate EnWave’s technology for the potential production of a variety of food applications. If the results from the planned technology evaluation are positive, Perdue will have an option to license the use of REV™ technology, on an exclusive basis, in the U.S. for a variety of food applications. All other terms of the Agreement are confidential.

About Perdue

Perdue Farms is dedicated to enhancing the quality of life for everyone they touch through innovative food and agricultural products. Since their beginning on Arthur Perdue’s farm in 1920, to their expansion into agribusiness and the introduction of the PERDUE® brand of chicken and turkey under Frank Perdue, and continuing with their third generation of leadership with Chairman Jim Perdue, they’ve remained family owned and family operated. They are the parent company of Perdue Foods and Perdue AgriBusiness. Through their PERDUE®, HARVESTLAND®, COLEMAN NATURAL®, COLEMAN ORGANIC®, ROCKY®, ROSIE®, and THE ORIGINAL BRAT HANS® brands; agricultural products and services; and stewardship and corporate responsibility programs, they are working to become the most trusted name in food and agricultural products. For more information on Perdue Farms visit www.perduefarms.com.

About EnWave

EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV™) dehydration technology.  EnWave aims to sign royalty-bearing commercial licenses with leading food and pharmaceutical companies for the use of its revolutionary technology.  Thus far the Company has signed twelve royalty-bearing licenses, opening up eight distinct market sectors for commercialization with companies. In addition to these licenses, EnWave has formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese® brand.

EnWave is introducing REV™ as a new dehydration standard in the food and biological material sectors: potentially faster and cheaper than freeze drying, with better end product quality than air drying or spray drying.  EnWave currently has three commercial REV™ platforms: nutraREV® is used in the food industry to dry food products quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour; powderREV® is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point and quantaREV® is used for continuous, high-volume low-temperature drying. Two additional platforms, bioREV® and freezeREV®, are being developed as new methods to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Dr. Tim Durance

President, CEO and Director

Suite 2000 - 1066 West Hastings St., Vancouver, B.C., CANADA V6E 3X2

Tel (604) 806-6110   Fax (604) 806-6112

TSX Venture Exchange trading symbol: ENW

www.enwave.net

For further information:

Mr. John Budreski, Executive Chairman, EnWave Corporation at +1 (416) 930-0914
E-mail: jbudreski@enwave.net

Mr. Brent Charleton, Senior Vice President, Corporate Affairs at +1 (778) 378-9616
E-mail: bcharleton@enwave.net  
 

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.